Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial
Simon Jochum, Imke Kirste, Sayuri Hortsch, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10

Showing 10 citing articles:

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
Nuri Lee, Seri Jeong, Su Kyung Lee, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1143-1143
Open Access | Times Cited: 30
In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose
Paola Stolfi, Filippo Castiglione, Enrico Mastrostefano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study
Ilya Kister, Y. Patskovsky, Ryan Curtin, et al.
Annals of Neurology (2022) Vol. 91, Iss. 6, pp. 782-795
Open Access | Times Cited: 24
Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study
Ilya Kister, Y. Patskovsky, Ryan Curtin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome
Ayşe Özdede, Okan Kadir Nohut, Zeynep Atlı, et al.
Rheumatology International (2022) Vol. 42, Iss. 10, pp. 1741-1750
Open Access | Times Cited: 3
Age- and sex-based changes in spike protein antibody status after SARS-CoV-2 vaccination and effect of past-infection in healthcare workers in Osaka
Shiro Hoshida, Nobuyuki Koeda, Hideki Hattori, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in Japan
Shinya Otsuka, Kei Hiraoka, Masato Suzuoki, et al.
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 4, pp. 539-542
Open Access | Times Cited: 1
Quantifying the vaccine-induced humoral immune response to spike-receptor binding domain as a surrogate for neutralization testing following mRNA-1273 (Spikevax) vaccination against COVID-19
Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies
Ilya Kister, Ryan Curtin, Jinglan Pei, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Age- and sex-based changes in spike protein antibody status after SARS-CoV-2 vaccination and effect of past-infection in healthcare workers in Osaka
Shiro Hoshida, Nobuyuki Koeda, Hideki Hattori, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top